3004 90 92 60

Code

3004 90 92 60

Type

10-digit tariff line

Duty rate

Free (set at subheading 30049092)

Unit

kg

Classification rulings (U.S. Customs, CROSS)

• N363288 · 2026-08-10 — The tariff classification of Tegoprazan Tablets in dosage form, from South Korea

  Tegoprazan, imported in 50 mg and 100 mg tablets, is a novel potassium-competitive acid blocker indevelopment for the treatment of adults with gastroesophageal reflux disease. A New Drug Application(NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval for threeindications: non-erosive reflux disease (NERD) erosive esophagitis (EE)healing, and EE maintenanc, e.In your letter, you suggest classification in subheading 3004.90.9255, Harmonized Tariff Schedule of theUnited States (HTSUS), which provides for “Containing pantoprazole or its salts.” We disagree. The…

• N333935 · 2023-07-28 — The tariff classification of Balsalazide Disodium Capsules USP and Carbidopa Tablets in dosage form, from Taiwan and India, respectively

  Balsalazide Disodium, imported in 750 mg capsules, is an anti-inflammatory drug that is indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. In your letter, you stated Balsalazide Disodium capsules will be imported from India. Carbidopa, imported in 25 mg tablets, is in a class of medications called decarboxylase inhibitors. It is indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic…

• N329717 · 2022-12-12 — The tariff classification of Loperamide Hydrochloride Capsules, USP and Methylene Blue Injection, USP in dosage form, from India and Italy, respectively

  Loperamide Hydrochloride, USP, imported in 2 mg capsules, is an anti-diarrheal agent. It is indicated for the control and symptomatic relief of acute nonspecific diarrhea in patients 2 years of age and older and of chronic diarrhea in adults associated with inflammatory bowel disease. Methylene Blue Injection, USP, imported in 5 mg, is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia. In your letter, you indicated this product will be imported from India. The applicable subheading for the Loperamide Hydrochloride Capsules, USP in dosage form will be…

• N328968 · 2022-11-21 — The tariff classification of Pantoprazole Sodium for Injection in dosage form, from India

  Pantoprazole Sodium for Injection, imported in 40 mg vials, belongs to a class of drugs called proton pump inhibitors (PPIs). It is indicated for the short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (GERD) and a history of erosive esophagitis (EE). It is also indicated for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome in adults. The applicable subheading for Pantoprazole Sodium for Injection in dosage form will be 3004.90.9260, Harmonized Tariff Schedule of the United States (HTSUS), which provides…

• N324975 · 2022-04-20 — The tariff classification of Fesoterodine Fumarate Extended-Release Tablets, Famotidine Tablets and Lenalidomide Capsules, in dosage form, from India

  Fesoterodine Fumarate, imported in 4 mg and 8 mg extended-release tablets, is an antimuscarinic drug. It is indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Famotidine, imported in 20 mg and 40 mg tablets, is a histamine H2 receptor antagonist. It is indicated for the treatment of active duodenal ulcer (DU), active gastric ulcer, symptomatic non-erosive gastroesophageal reflux disease (GERD), and erosive esophagitis due to GERD, diagnosed by biopsy. It is also indicated in adult patients for the treatment of…

• 3004 90 92 39 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing phenytoin or its salts
• 3004 90 92 40 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing propofol or its salts
• 3004 90 92 41 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing levetiracetam, phenytoin or their…
• 3004 90 92 42 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing etomidate or its salts
• 3004 90 92 43 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Other
• 3004 90 92 44 — Other: — Medicaments primarily affecting the central nervous system: — Antidepressants, tranquilizers, and other psychotherapeutic agents: — Containing…
• 3004 90 92 45 — Other: — Medicaments primarily affecting the central nervous system: — Antidepressants, tranquilizers, and other psychotherapeutic agents: — Containing…
• 3004 90 92 46 — Other: — Medicaments primarily affecting the central nervous system: — Antidepressants, tranquilizers, and other psychotherapeutic agents: — Other
• 3004 90 92 47 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Containing rocuronium or its salts
• 3004 90 92 48 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Containing succinylcholine or its salts
• 3004 90 92 49 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Other
• 3004 90 92 50 — Other: — Dermatological agents and local anesthetics: — Containing lidocaine or its salts
• 3004 90 92 51 — Other: — Dermatological agents and local anesthetics: — Other
• 3004 90 92 52 — Other: — Medicaments primarily affecting the digestive system: — Laxatives
• 3004 90 92 53 — Other: — Medicaments primarily affecting the digestive system: — Antacids
• 3004 90 92 54 — Other: — Medicaments primarily affecting the digestive system: — Containing famotidine or its salts
• 3004 90 92 55 — Other: — Medicaments primarily affecting the digestive system: — Containing pantoprazole or its salts
• 3004 90 92 56 — Other: — Medicaments primarily affecting the digestive system: — Containing ondansetron or its salts
• 3004 90 92 57 — Other: — Medicaments primarily affecting the digestive system: — Containing glycopyrrolate or its salts
• 3004 90 92 58 — Other: — Medicaments primarily affecting the digestive system: — Containing loperamide or its salts
• 3004 90 92 61 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Containing furosemide and its salts
• 3004 90 92 62 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Containing hydrochlorothiazide or its salts
• 3004 90 92 63 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Other
• 3004 90 92 64 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Containing calcium gluconate
• 3004 90 92 65 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Containing potassium chloride
• 3004 90 92 66 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Containing sodium bicarbonate, in injection form
• 3004 90 92 67 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Other
• 3004 90 92 68 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Cough and cold preparations
• 3004 90 92 69 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Antihistamines: — Containing diphenhydramine or its salts
• 3004 90 92 70 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Antihistamines: — Other
• 3004 90 92 71 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Containing albuterol sulfate
• 3004 90 92 72 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Other: — Containing timolol maleate
• 3004 90 92 73 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Other: — Other
• 3004 90 92 74 — Other: — Other: — Containing heparin sodium or its salts
• 3004 90 92 75 — Other: — Other: — Containing zoledronic acid or its salts
• 3004 90 92 76 — Other: — Other: — Other

• 30049 — ТН ВЭД ЕАЭС: прочие:
• 300490 — EU CN/TARIC: Other

Related news

• FMC proposes $200,000 fee on Spanish-flag ships and curbs on Spanish imports
• BIS details zero-tariff drug categories ahead of September 29 tariff

Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.